Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia
Lukas Weiß(Paracelsus Medical University), Inge Tinhofer(Paracelsus Medical University), Christoph Grabmer(Paracelsus Medical University), Alexander Egle(Paracelsus Medical University), Richard Greil(Paracelsus Medical University), Thomas Melchardt(Paracelsus Medical University)
Cited by 65
Related Papers
Bim is a suppressor of Myc-induced mouse B cell leukemia
|Proceedings of the National Academy of Sciences|2004|482
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
|The Lancet Haematology|2020|351
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
|The Lancet Infectious Diseases|2021|344
Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas
|International Journal of Mass Spectrometry|2007|276
Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group
|Journal of Clinical Oncology|2011|190